AzTrials
AzTrials

PainNCT05727969

Dexmedetomidine Infusion and Surgical Pleth Index In Pediatrics

A study testing Dexmedetomidine, Lactated Ringer and Hypospadias in people with Pain and Hypospadias, run by Fayoum University Hospital at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This non-invasive dimensionless score index -SPI-reflects the Patients' sympathetic response to surgical stimulation. Its effectiveness in detecting the balance between nociceptor activation and analgesia was not only reported but also, was reported to be superior to the other parameters like blood pressure and heart… Read more about this study

Who is it for?
Ages 1 year to 7 yearsHealthy volunteers can take part
Conditions the study is for
Pain, Hypospadias
What is being tested?
Dexmedetomidine, Lactated Ringer and Hypospadias
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
90 participants
Where
1 siteEgypt
Study dates
15 Jan 2023to 15 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 7 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Age 1-7years.
  • ASA physical status I-II.
  • Hypospadias surgery.

Who cannot join

  • Children having a history of mental retardation.
  • Developmental delay.
  • Allergic to dexmedetomedine.
  • Neuraxial anesthesia.
  • Cardiovascular disease.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Fayoum University hospital

    El Fayoum Qesm, Faiyum Governorate, 63514

Other trials in Egypt

About this study

Official title: Effect Of Dexmedetomidine Infusion On Surgical Pleth Index In Pediatrics Undergoing Hypospadias Repair; A Prospective Observational Study

This non-invasive dimensionless score index -SPI-reflects the Patients' sympathetic response to surgical stimulation. Its effectiveness in detecting the balance between nociceptor activation and analgesia was not only reported but also, was reported to be superior to the other parameters like blood pressure and heart rate. SPI value is correlated to pain and ranges from 0 to 100, higher values indicate strong surgical stimulus. Its value is obtained from photoplethysmographic amplitude (PPGA) and heart rate (HR) data from pulse oximetry measurement.

Prediction of the severity of postoperative pain using SPI in both adults and children has been reported by several studies. So, the authors hypothesize that dexmedetomidine infusion without giving a bolus dose may affect the SPI in pediatrics undergoing hypospadias repair.

Read the detailed description

After obtaining Fayoum University's ethical committee permission and as well as the informed consent from the parents, 90 patients aged 1 to 7 years old scheduled for hypospadias repair will be randomly assigned into 2 groups.

Preoperative Assessment:

All patients will be assessed clinically and investigated for exclusion of any of the above-mentioned contraindications.

Perioperative Management:

Patients will receive no premedication. After entering the Operating room, All patients will be monitored using surgical pleth index, arterial blood pressure, pulse oximetry, and electrocardiography. The SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system.

Inhalational induction of general anesthesia (GA) will be performed with a face mask using sevoflurane 8% and 50% oxygen in the air, and then an intravenous (IV) cannula will be inserted.

Fentanyl will be administered intravenously at 1 μg/kg, atracurium 0.5 mg/kg and an endotracheal tube will be used to secure the airway.

Anesthesia will be maintained with 1% isoflurane, 50% oxygen in the air, and atracurium infusion (0.10 mg/kg).

During the operation, bradycardia is defined as a 30% decrease from the baseline HR, and hypotension is defined as a 30% decrease from the baseline MAP. In these cases, 0.01 mg/kg of atropine and 0.1 mg/kg of ephedrine, respectively, will be given intravenously. Additionally, tachycardia is defined as a 30% increase from the baseline HR, and hypertension is defined as a 30% increase from the baseline MAP. If either of these occurred, 0.1 μg/kg of fentanyl was given intravenously, and then the incidence was calculated and analyzed.

At the end of the surgery, acetaminophen 15 mg/kg IV will be administered to all patients. After completion of the surgical procedure and emergence from anesthesia, the patient will be referred to PACU. Quality of analgesia will be assessed using a face, legs, activity, cry, consolability (FLACC scale) at PACU discharge and 2, 4, 6, 12, and 24 hours postoperatively. Diclofenac sodium 1 mg/kg rectally will be given as rescue analgesia for patients in all study groups in PACU if the FLACC scale > 4. Nurses will be informed about the pain evaluation, to give the patients oral paracetamol 30 mg/kg. The data collectors from nurses will record data. The depth of sedation will be assessed using Ramsy sedation score (RSS) at PACU discharge and 2 hours postoperative by the investigators.

The patient will be discharged from PACU using The Modified Aldrete Score system after an assessment of the patient's activity, respiration, blood pressure, consciousness, and color, A score ≥ 9 is required for discharge from the PACU.

Adverse events like bradycardia hypotension excessive sedation respiratory depression postoperative agitation nausea and vomiting will be recorded during the first 24 hours.

Statistical analysis

  • Sample size calculation was done using IBM SPSS version 29 for Windows. A total of 45 children per group are needed to be able to detect an expected difference in the SPI based on previous research.This sample size was estimated using a power of 80% and alpha of 0.05.
  • Descriptive statistics for the variables will be presented in the form of mean with standard deviation or median with interquartile range for numeric variables, while frequencies and percentages will be used for categorical variables. Comparison of the two groups will be done after testing for normality of the distribution using Shapiro-wilk test. The analysis will be done using the independent samples t test or using the non-parametric Mann Whitney test for numerical variables. Categorical variables will be compared using Chi Square test or Fisher's exact test. IBM SPSS version 28 for Windows software will be used for the analysis. A p-value of < 0.05 will be considered statistically significant.
Conditions
Pain, Hypospadias
Being tested
Dexmedetomidine, Lactated Ringer, Hypospadias, Surgical pleth index
Keywords
Dexmedetomidine, Hypospadias, Postoperative analgesia, Surgical pleth index
Medical subject headings
Pain, Hypospadias

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DexmedetomidineDrug

    Also called Precedex

    Dexmedetomidine at a a rate of 0.5 μg/kg/hour will be infused with induction of anesthesia.

  • Lactated RingerDrug

    Also called Solution

    Lactated ringer solution at a a rate of 0.5 μg/kg/hour will be infused with induction of anesthesia.

  • HypospadiasProcedure or surgery

    Also called pediatric manuvere

    Children who will undergone hypospadias surgery

  • Surgical pleth indexDevice

    Also called SPI

    The SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system.

Study groups in NCT05727969
Study groupRoleWhat they receive
Control groupPlacebo comparatorThe control group, lactated ringer solution will be infused.
Receives: Drug: Lactated Ringer; Procedure: Hypospadias; Device: Surgical pleth index
Dexmedetomidine groupExperimentalIn the dexmedetomidine group, dexmedetomidine will be infused.
Receives: Drug: Dexmedetomidine; Procedure: Hypospadias; Device: Surgical pleth index

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Surgical pleth index number

    from 0 to 100, higher values indicate strong surgical stimulus

    Measured: 1 minute at end of the operation after skin closure.

Secondary outcomes (27)
  1. Surgical pleth index number

    from 0 to 100, higher values indicate strong surgical stimulus

    Measured: 1 minute before induction of anesthesia.

  2. Surgical pleth index number

    from 0 to 100, higher values indicate strong surgical stimulus

    Measured: 1 minute after insertion of endotracheal tube.

  3. Surgical pleth index number

    from 0 to 100, higher values indicate strong surgical stimulus

    Measured: 1 minute after beginning of surgery with skin incision.

  4. Surgical pleth index number

    from 0 to 100, higher values indicate strong surgical stimulus

    Measured: 5 minutes after recovery at post anesthesia care unit.

  5. Mean arterial blood pressure

    in mmHg

    Measured: 5 minutes after recovery at post anesthesia care unit.

  6. Mean arterial blood pressure

    in mmHg

    Measured: 1 minute before induction of anesthesia.

  7. Mean arterial blood pressure

    in mmHg

    Measured: 1 minute after beginning of surgery with skin incision.

  8. Heart rate

    beat/minute

    Measured: 1 minute after beginning of surgery with skin incision.

  9. Heart rate

    beat/minute

    Measured: 1 minute before induction of anesthesia.

  10. Heart rate

    beat/minute

    Measured: 5 minutes after recovery at post anesthesia care unit.

  11. Heart rate

    beat/minute

    Measured: 1 minute at end of the operation after skin closure.

  12. Mean arterial blood pressure

    mmHg

    Measured: 1 minute at end of the operation after skin closure.

  13. Need of vasoactive drugs

    Yes or no

    Measured: 1minute after infusion until end of surgery

  14. FLACC pain score

    F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children

    Measured: 5 minutes after recovery in postanesthesia care unit

  15. FLACC pain score

    F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children

    Measured: 2 hours after recovery in postanesthesia care unit

  16. Ramsay sedation score

    0:5 with 0:deeply sedation to 5:no sedation

    Measured: 5 minutes after recovery in postanesthesia care unit

  17. Ramsay sedation score

    0:5 with 0:deeply sedation to 5:no sedation

    Measured: 2 hours after recovery in postanesthesia care unit

  18. FLACC pain score

    F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children

    Measured: 4 hours after discharge from recovery

  19. FLACC pain score

    F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children

    Measured: 6 hours after discharge from recovery

  20. FLACC pain score

    F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children

    Measured: 12 hours after discharge from recovery

  21. FLACC pain score

    F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children

    Measured: 24 hours after discharge from recovery

  22. Surgical time

    from when the surgeon of record starts the procedure until complete skin closure in minutes

    Measured: 1 minute after skin

  23. Anesthesia time

    from the start of anesthesia to the end of an anesthesia service in minutes

    Measured: 5 minutes after insertion of endotracheal tube

  24. Total opioid consumption

    in milligram

    Measured: 24 hours after operation

  25. Time of 1st analgesia dose

    time when first analgesic drug is injected for pain (in hours)

    Measured: 24 hours postoperatively

  26. Total non-steroidal consumption

    time when first usage of non-steroidal anti-inflammatory drug is injected for pain (in hours)

    Measured: 24 hours postoperatively

  27. Extubation time

    time from the end of surgery to airway extubation (in minutes)

    Measured: 2 minutes after removal of endotracheal tube

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2023
  2. Study start15 Jan 2023
  3. Primary completion15 Nov 2023
  4. Study completion15 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
The randomization will be computer generated random number and the randomization sequence will be kept hidden in sealed opaque envelopes just opened after recruitment and admittance to the operating room.
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05727969
Sponsor's protocol ID
M637
Status last verified
Feb 2024
First submitted
24 Jan 2023
Last updated
22 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Huiku M, Uutela K, van Gils M, Korhonen I, Kymalainen M, Merilainen P, Paloheimo M, Rantanen M, Takala P, Viertio-Oja H, Yli-Hankala A. Assessment of surgical stress during general anaesthesia. Br J Anaesth. 2007 Apr;98(4):447-55. doi: 10.1093/bja/aem004. Epub 2007 Feb 28.

    PubMed 17329347
  • Hamunen K, Kontinen V, Hakala E, Talke P, Paloheimo M, Kalso E. Effect of pain on autonomic nervous system indices derived from photoplethysmography in healthy volunteers. Br J Anaesth. 2012 May;108(5):838-44. doi: 10.1093/bja/aes001. Epub 2012 Feb 26.

    PubMed 22369767
  • Constant I, Sabourdin N. Monitoring depth of anesthesia: from consciousness to nociception. A window on subcortical brain activity. Paediatr Anaesth. 2015 Jan;25(1):73-82. doi: 10.1111/pan.12586. Epub 2014 Nov 20.

    PubMed 25410376

Questions about this trial

What is this clinical trial studying?

A study testing Dexmedetomidine, Lactated Ringer and Hypospadias in people with Pain and Hypospadias, run by Fayoum University Hospital at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Surgical pleth index number (time frame: 1 minute at end of the operation after skin closure.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05727969, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2024; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in